MPM BioImpact LLC - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 168 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.3%.

Quarter-by-quarter ownership
MPM BioImpact LLC ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q1 2022$9,434,000
-27.1%
351,350
+29.5%
2.53%
+7.3%
Q4 2021$12,943,000
-28.2%
271,3500.0%2.36%
-15.6%
Q3 2021$18,026,000
-14.2%
271,350
+0.8%
2.80%
-19.0%
Q2 2021$21,002,000
-17.5%
269,1860.0%3.45%
+7.8%
Q1 2021$25,462,000
-66.2%
269,186
-56.4%
3.20%
-50.8%
Q4 2020$75,226,000
+179.0%
617,372
+100.0%
6.50%0.0%
Q3 2020$26,967,000
+35.3%
308,6860.0%6.50%
+22.6%
Q2 2020$19,938,000
+44.6%
308,6860.0%5.30%
-37.1%
Q1 2020$13,786,000308,6868.42%
Other shareholders

There were no reported owners of TURNING POINT THERAPEUTICS I in Q3 2020.

NameSharesValueWeighting ↓
View complete list of TURNING POINT THERAPEUTICS I shareholders